Sanofi patents expiration
1. Renvela patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7985418 | SANOFI | Aliphatic amine polymer salts for tableting |
Oct, 2025
(2 years from now) | |
Drugs and Companies using SEVELAMER CARBONATE ingredient
Market Authorisation Date: 19 October, 2007
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of RENVELA before it's drug patent expiration?
More Information on Dosage
RENVELA family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic